Press release
12.12.2023 To the attention of interested persons First version of the Union list of critical medicines agreed to help avoid […]
Press release
12.12.2023 To the attention of interested persons Questions and answers on the Union list of critical medicines download document …
Press release
01.12.2023 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023 download […]
Important notification
01.11.2023 To the attention of marketing authorization holders Regarding Direct healthcare professional communications, we want to inform you of the […]
Press release
31.10.2023 To the attention of interested persons EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 download document […]
Press release
18.10.2023 To the attention of interested persons EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens […]
Press release
06.10.2023 To the attention of interested persons Revised transparency rules for the EU Clinical Trials Information System (CTIS) download document […]
Press release
26.09.2023 To the attention of interested persons The Ministry of Health and the National Agency for Medicines and Medical Devices […]
Press release
14.09.2023 To the attention of interested persons Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 download document […]
Press release
01.09.2023 To the attention of interested persons PRAC recommends new measures to avoid topiramate exposure in pregnancy download document …